Sun.Nov 10, 2024

article thumbnail

‘What’s your pain right now?’ Sickle cell, loss, and survival in America

STAT

ST. LOUIS — All morning, nurses had been coming in, taking vitals, offering blankets, pressing buttons to silence alarms. It would stay quiet for a bit, but then the beeping would start again, telling Tammy Clemons over and over that she was back in the emergency room. She wished she were elsewhere. She wished she were with her sister, who’d just had a stillborn baby in a different hospital, three miles away.

Hospitals 334
article thumbnail

Aignostics leads latest crop of digital health financings

pharmaphorum

Recent funding rounds in the digital health arena feature digital pathology startup Aignostics, remote care specialists TCC, Yazen Health, and Nema Health, wearables developer Alimetry, and clinical trial automation startup Research Grid.Digital pathology specialist Aignostics, which develops artificial intelligence algorithms to glean information from medical images and combine it with epidemiological, clinical, and genomic data, has completed a $34 million Series B financing.

99
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Lupin receives tentative U.S. FDA approval for Raltegravir tablets

Express Pharma

Lupin, a global pharmaceutical company, has announced its tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Raltegravir Tablets USP, 600 mg. The approval enables Lupin to market a generic equivalent of Isentress HD Tablets, 600 mg, produced by Merck Sharp & Dohme LLC. Lupin is the exclusive first-to-file applicant for this product, potentially granting it a 180-day exclusivity period in the U.S. market.

article thumbnail

J&J bids to add smouldering myeloma to Darzalex label

pharmaphorum

Johnson & Johnson looks on course to make Darzalex the first approved drug therapy for smouldering multiple myeloma, after a phase 3 win

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Regulator and Funder? FDA’s Orphan Products Grants Program awards significant funding to help move promising treatments through clinical development

FDA Law Blog: Biosimilars

By Sarah Wicks & James E. Valentine — The U.S. Food and Drug Administration (FDA) plays a pivotal role in fostering the development of treatments for rare diseases through its Orphan Products Grants Program. Each year, FDA selects a limited number of clinical trials to fund to help sponsors pursue development of medical products for rare diseases and advance their field.

article thumbnail

2025 BCPS Study Materials $100 Discount AND FREE Audible Book!

Med Ed 101

Are you gearing up for the BCPS exam in 2025 and looking for the best resources to help you succeed? We’ve got some exciting news that will make your preparation easier and more affordable! For a limited time, we’re offering $100 OFF our comprehensive BCPS Exam Study Materials (1 Year All Access Pass), designed by […] The post 2025 BCPS Study Materials $100 Discount AND FREE Audible Book!

59

More Trending

article thumbnail

Episode 973: A tip for predicting the pharmacotherapy needs of your patient in rapid response or emergent situations

Pharmacy Joe

In this episode, I’ll discuss a tip to predict pharmacotherapy needs in rapid response or emergent situations. Episode 973: A tip for predicting the pharmacotherapy needs of your patient in rapid response or emergent situations Subscribe on iTunes , Android , or Stitcher At the beginning of any rapid response or emergent procedure such as rapid sequence intubation, make a note of your patient’s starting heart rate, rhythm, oxygen saturation, and blood pressure.

article thumbnail

Hiccups

RX Note

Introduction A hiccup occurs due to an involuntary, intermittent, spasmodic contraction of the diaphragm and intercostal muscles. Although hiccups most commonly are self-limited (last for 48 hours are classified as persistent, while those lasting >1 month are considered intractable. Management Treatment of hiccups should be focused on the underlying cause when possible.

52
article thumbnail

Investment surges, hurdles and emerging innovations in neuroscience

Pharmaceutical Technology

Experts in the neuropsychiatry drug development space say targeting the right patient population will be key for success in the field.

article thumbnail

Compression Stockings

RX Note

Introduction Compression stockings are special, snug-fitting socks used to help prevent swelling and improve blood flows in the legs. Compression stockings are recommended when you sit or stand for long periods without moving, such as during a long flight. They may also be used during pregnancy to reduce the risk of developing lower limb oedema, varicose veins and deep vein thrombosis.

52
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Drug Patent Expirations for the Week of November 10, 2024

Drug Patent Watch

PONVORY (ponesimod) Vanda pharms inc Patent: 9,000,018 Expiration: Nov 16, 2024 See More … Source

52
article thumbnail

Researchers Assess the Role of Vitamin K2 in Managing Nocturnal Leg Cramps

Pharmacy Times

Vitamin K2 displayed a marked reduction in cramp frequency compared to a placebo.

52